fda warning letter bpc-157 unapproved drug The is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW ⬇️ FTC and U.S. FDA Warning
Description
Quorum Sensing Inhibitors (QSIs) 3.3.1
Comparisons may be made against VEGF or other angiogenic factors

Athletes love it for joint repair

The literature reports BPC-157 as stable only under deep-freeze storage (below roughly 18 to 20C), and critical attributes needed to establish identity, strength, quality, and purity were not consistently available

discussion 159-163, 211-158